Ocular Surface Disease, Vision-Related Quality Of Life, And Psychological Status In Glaucoma Patients
Published 2026 - 44th Congress of the ESCRS
Reference: POCOR434 | Type: Free paper | DOI: 10.82333/gyy8-0p09
Authors: A/Prof. Geeta Behera* 1 , Dr Kumaradharshini V M 1 , Prof. Subashini Kaliaperumal 1
1Ophthalmology,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),Puducherry,India
Purpose
To evaluate ocular surface disease (OSD), vision-related quality of life, and psychological status in glaucoma patients, and explore their treatment-related burdens and expectations.
Setting
Tertiary care centre in South India
Methods
121 glaucoma patients on medical and/or surgical treatment were evaluated for OSD: ocular surface disease (OSDI), standardised patient evaluation of eye dryness (SPEED), Schirmer I, and tear-film breakup time (TBUT), vision-related quality of life (QoL) by the National Eye Institute, visual functioning questionnaire (NEI VFQ-25), and psychological assessment by hospital anxiety and depression scale (HADS).
Results
Average age:59.6±12.5years, primary open-angle glaucoma:78%, medical therapy:55.4%, post-glaucoma surgery:45% (34% on glaucoma medications). Percentage of patients with dry eye by OSDI:55.4%, SPEED:73.6%, Schirmer’s I:26.4%, TBUT:56.2%. The mean NEI VFQ-25 score was 78.5±16.6, with greatest impairments in general vision, driving, ocular pain, and role difficulties. QoL significantly worsened with increasing use of antiglaucoma medications (p=0.007). Patients with OSD had significantly lower QoL and subscale scores of general vision, ocular pain, near activities, distance activities, mental health, role difficulties, driving, and dependency. 41.3% had anxiety, and 28.1% had depression on HADS, and anxiety was more common in dry eye patients.
Conclusions
Glaucoma patients suffer from dry eye disease (>50%) and poor quality of life, related to greater medication use. They also suffer from anxiety and depression, needing mental health interventions.